The Cerebellum

, Volume 1, Issue 2, pp 143–158 | Cite as

The Hereditary Ataxias

A symposium of the Society for Experimental Neuropathology under the auspices of the American Neurological Association
Article
  • 61 Downloads

Keywords

Purkinje Cell Polyglutamine Spinocerebellar Ataxia Idebenone Spinocerebellar Ataxia Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Friedreich N. Ueber degenerative Atrophie der spinalen Hinter-stränge. Virchows Arch Pathol Anat Physiol Klin Med 1863; 26: 391–419.CrossRefGoogle Scholar
  2. 2.
    Friedreich N. Ueber degenerative Atrophie der spinalen Hinter-stränge. Virchows Arch Pathol Anat Physiol Klin Med 1863; 26: 433–459.Google Scholar
  3. 3.
    Friedreich N. Ueber degenerative Atrophie der spinalen Hinter-stränge. Virchows Arch Pathol Anat Physiol Klin Med 1863; 27: 1–26.CrossRefGoogle Scholar
  4. 4.
    Friedreich N. Ueber Ataxie mit besonderer Berücksichtigung der hereditären Formen. Virchows Arch Pathol Anat Physiol Klin Med 1876; 68: 145–245.Google Scholar
  5. 5.
    Friedreich N. Ueber Ataxie mit besonderer Berücksichtigung der hereditären Formen (Nachtrag [Postscriptum]) Virchows Arch Pathol Anat Physiol Klin Med 1877; 70: 140–152.CrossRefGoogle Scholar
  6. 6.
    Mott FW. Case of Friedreich’s disease, with autopsy and systematic microscopical examination of the nervous system. Arch Neurol Psychiat 1907; 3: 180–200.Google Scholar
  7. 7.
    Lamarche JB., Côté M., Lemieux B. The cardiomyopathy of Friedreich’s ataxia. Morphological observations in 3 cases. Can J Neurol Sci 1980; 7: 389–396.PubMedGoogle Scholar
  8. 8.
    Campuzano V., Montermini L., Moltò MD, et al. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423–1426.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Campuzano V., Montermini L., Moltó MD, et al. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423–1427.PubMedCrossRefGoogle Scholar
  2. 2.
    Montermini L., Richter A., Morgan K, et al. Phenotypic variability in Friedreich’s ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol 1997; 41: 675–68.PubMedCrossRefGoogle Scholar
  3. 3.
    Pianese L., Cavalcanti F., De Michele G, et al. The effect of parental gender on the GAA dynamic mutation in the FRDA gene. Am J Hum Genet 1997; 60: 460–463.PubMedGoogle Scholar
  4. 4.
    Montermini L., Kish SJ., Jiralerspong S, et al. Somatic mosaicism for the Friedreich’s ataxia GAA triplet repeat expansions in the central nervous system. Neurology 1997; 49: 606–610.PubMedGoogle Scholar
  5. 5.
    Cossée M., Schmitt M., Campuzano V, et al. Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci USA 1997; 94: 7452–7457.PubMedCrossRefGoogle Scholar
  6. 6.
    Monros E., Moltó MD., Martinez F, et al. Phenotype correlation and intergenerational dynamics of the Friedreich’s ataxia GAA trinucleotide repeat. Am J Hum Genet 1997; 61: 101–110.PubMedCrossRefGoogle Scholar
  7. 7.
    Campuzano V., Montermini L., Lutz Y, et al. Frataxin is reduced in Friedreich’s ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6: 1771–1780.PubMedCrossRefGoogle Scholar
  8. 8.
    Sakamoto N., Chastain PD., Parniewski P, et al. Sticky DNA: self-association properties of long GAA·TTC repeats in R·R·Y triplex structures from Friedreich’s ataxia. Mol Cell 1999; 3: 465–475.PubMedCrossRefGoogle Scholar
  9. 9.
    Ohshima K., Sakamoto N., Labuda M, et al. A non-pathogenic GAAGGA repeat in the frataxin gene: implications for the Friedreich’s ataxia GAA triplet repeat. Neurology 1999; 53: 1854–1857.PubMedGoogle Scholar
  10. 10.
    Duval-Valentin G., Thuong NG., Hélène C. Specific inhibition of transcription by triple-helix forming oligonucleotides. Proc Natl Acad Sci USA 1992; 89: 504–508.PubMedCrossRefGoogle Scholar
  11. 11.
    Ohshima K., Montermini L., Wells RD., Pandolfo M. Inhibitory effects of expanded GAATTC triplet repeats from intron I of the Friedreich’s ataxia gene on transcription and replication in vivo. J Biol Chem 1998; 273: 14588–15595.PubMedCrossRefGoogle Scholar
  12. 12.
    Bidichandani SI., Ashizawa T., Patel PI. Atypical Friedreich’s ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet 1997; 60: 251–1256.Google Scholar
  13. 13.
    Grabczyk E., Usdin K. The GAA*TTC triplet repeat expanded in Friedreich’s ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucl Acids Res 2000; 28: 2815–2822.PubMedCrossRefGoogle Scholar
  14. 14.
    Sakamoto N., Ohshima K., Montermini L, et al. Sticky DNA, a self-associated complex formed at long GAA·TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J Biol Chem 2001; 276: 27171–27177.PubMedCrossRefGoogle Scholar
  15. 15.
    Montermini L., Andermann E., Labuda M, et al. The Friedreich’s ataxia GAA triplet repeat: premutation and normal alleles. Hum Mol Genet 1997; 6: 1261–1266.PubMedCrossRefGoogle Scholar
  16. 16.
    Sakamoto N., Larson JE., Iyer RR, et al. GGA·TCC interrupted triplets in long GAA·TTC repeats inhibit the formation of triplex and sticky DNA structures, alleviate transcription inhibition, and reduce genetic instabilities. J Biol Chem 2001; 276: 27178–27187.PubMedCrossRefGoogle Scholar
  17. 17.
    Campuzano V., Montermini L., Lutz Y, et al. Frataxin is reduced in Friedreich’s ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6: 1771–1780.PubMedCrossRefGoogle Scholar
  18. 18.
    Cossée M., Campuzano V., Koutnikova H, et al. Frataxin fracas. Nat Genet 1997; 15: 337–33.PubMedCrossRefGoogle Scholar
  19. 19.
    Filla A., De Michele G., Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich’s ataxia. Am J Hum Genet 1996; 59: 554–56.PubMedGoogle Scholar
  20. 20.
    Dürr A., Cossée M., Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 1996; 335: 1169–1175.PubMedCrossRefGoogle Scholar
  21. 21.
    Lamont PJ., Davis MB., Wood NW. Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich’s ataxia in 56 patients-clinical and genetic correlates. Brain 1997; 120: 673–680.PubMedCrossRefGoogle Scholar
  22. 22.
    Schöls L., Amoiridis G., Przuntek H, et al. Friedreich’s ataxia. Revision of the phenotype according to molecular genetics. Brain 1997; 120: 2131–2140.Google Scholar
  23. 23.
    Cossée M., Dürr A., Schmitt M, et al. Frataxin point mutations and clinical presentation of compound heterozygous Friedreich’s ataxia patients. Ann Neurol 1999; 45: 200–206.PubMedCrossRefGoogle Scholar
  24. 24.
    Cossée M., Puccio H., Gansmuller A, et al. Inactivation of the Friedreich’s ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet 2000; 9: 1219–1226.PubMedCrossRefGoogle Scholar
  25. 25.
    De Michele G., Filla A., Cavalcanti F, et al. Atypical Friedreich’s ataxia phenotype associated with a novel missense mutation in the X25 gene. Neurology 2000; 54: 496–499.PubMedGoogle Scholar

References

  1. 1.
    Campuzano V., Montermini L., Molto MD, et al. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423–1427.PubMedCrossRefGoogle Scholar
  2. 2.
    Cossee M., Puccio H., Gansmuller A, et al. Inactivation of the Friedreich’s ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet 2000; 9: 1219–1226.PubMedCrossRefGoogle Scholar
  3. 3.
    Patel PI., Isaya G. Friedreich’s ataxia: from GAA triplet-repeat expansion to frataxin deficiency. Am J Hum Genet 2001; 69: 15–24.PubMedCrossRefGoogle Scholar
  4. 4.
    Campuzano V., Montermini L., Lutz Y, et al. Frataxin is reduced in Friedreich’s ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6: 1771–1780.PubMedCrossRefGoogle Scholar
  5. 5.
    Koutnikova H., Campuzano V., Foury F, et al. Studies of human, mouse, and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997; 16: 345–351.PubMedCrossRefGoogle Scholar
  6. 6.
    Wilson RB., Roof DM. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet 1997; 16: 352–357.PubMedCrossRefGoogle Scholar
  7. 7.
    Cavadini P., Gellera C., Patel PI, et al. Human frataxin maintains mitochondrial iron homeostasis inSaccharomyces cerevisiae. Hum Mol Genet 2000; 9: 2523–2530.PubMedCrossRefGoogle Scholar
  8. 8.
    Babcock M., de Silva D., Oaks R, et al. Regulation of mitochondrial iron accumulation by YFH 1p, a putative homolog of Frataxin. Science 1997; 276: 1709–1712.PubMedCrossRefGoogle Scholar
  9. 9.
    Radisky DC., Babcock MC., Kaplan JK. The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle. J Biol Chem 1999; 274: 4497–4499.PubMedCrossRefGoogle Scholar
  10. 10.
    Foury F., Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich’s ataxia elicits iron accumulation in mitochondria. FEBS Lett 1997; 411: 373–377.PubMedCrossRefGoogle Scholar
  11. 11.
    Foury F. Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain. FEBS Lett 1999; 456: 281–284.PubMedCrossRefGoogle Scholar
  12. 12.
    Adamec J., Rusnak F., Owen WG, et al. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich’s ataxia. Am J Hum Genet 2000; 67: 549–562.PubMedCrossRefGoogle Scholar
  13. 13.
    Lamarche JB., Cote M., Lemieux B. The cardiomyopathy of Friedreich’s ataxia morphological observations in 3 cases. Can J Neurol Sci 1980; 7: 389–396.PubMedGoogle Scholar
  14. 14.
    Rötig A., de Lonlay P., Chretien D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich’s ataxia. Nat Genet 1997; 17: 215–217.PubMedCrossRefGoogle Scholar
  15. 15.
    Bradley JL., Blake JC., Chamberlain S, et al. Clinical, biochemical and molecular genetic correlations in Friedreich’s ataxia. Hum Mol Genet 2000; 9: 275–282.PubMedCrossRefGoogle Scholar
  16. 16.
    Lodi R., Cooper JM., Bradley JL, et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich’s ataxia. Proc Natl Acad Sci USA 1999; 96: 11492–11495.PubMedCrossRefGoogle Scholar
  17. 17.
    Delatycki MB., Camakaris J., Brooks H, et al. Direct evidence that mitochondrial iron accumulation occurs in Friedreich’s ataxia. Ann Neurol 1999; 45: 673–675.PubMedCrossRefGoogle Scholar
  18. 18.
    Wong A., Yang J., Cavadini P, et al. The Friedreich’s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 1999; 8: 425–430.PubMedCrossRefGoogle Scholar
  19. 19.
    Wilson RB., Lynch DR., Brooks DG, et al. Increased serum transferrin receptor concentrations in Friedreich’s ataxia. Ann Neurol 2000; 47: 659–661.PubMedCrossRefGoogle Scholar
  20. 20.
    Emond M., Lepage G., Vanasse M, et al. Increased levels of plasma malondialdehyde in Friedreich’s ataxia. [see comments]. Neurology 2000; 55: 1752–1753.Google Scholar
  21. 21.
    Puccio H., Simon D., Cossee M, et al. Mouse models for Friedreich’s ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001; 27: 181–186.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen OS., Kaplan J. CCC1 suppresses mitochondrial damage in the yeast model of Friedreich’s ataxia by limiting mitochondrial iron accumulation. J Biol Chem 2000; 275: 7626–7632.PubMedCrossRefGoogle Scholar
  23. 23.
    Rustin P., von Kleist-Retzow JC., Chantrel-Groussard K, et al. Effect of idebenone on cardiomyopathy in Friedreich’s ataxia: a preliminary study. Lancet 1999; 354: 477–479.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Bouchard JP., Richter A., Mathieu J, et al. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuromuscul Disord 1998; 8: 474–479.PubMedCrossRefGoogle Scholar
  2. 2.
    Engert JC., Berube P., Mercier J. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet 2000; 24: 120–125.PubMedCrossRefGoogle Scholar
  3. 3.
    Richter A., Rioux JD., Bouchard JP, et al. Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. Am J Hum Gen 1999; 64: 768–775.CrossRefGoogle Scholar
  4. 4.
    Peyronnard JM., Charron I., Barbeau A. The neuropathy of Charlevoix-Saguenay ataxia: an electrophysiological and pathological study. Can J Neurol Sci 1979; 6: 199–203.PubMedGoogle Scholar
  5. 5.
    Mrissa N., Belals S., Hamida CB, et al. Linkage to chromosome 13q11–12 of an autosomal recessive cerebellar ataxia in a Tunisian family. Neurology 2000; 54: 1408–1414.PubMedGoogle Scholar
  6. 6.
    Pulst S-M., Filla A. Ataxias on the march from Quebec to Tunisia. Neurology 2000; 54: 1400–1401.PubMedGoogle Scholar
  7. 7.
    Pascual-Castroviejo I., Pascual-Pascual SI., Viano J., Martinez V. Ataxia espástica recessiva tipo Charlevoix-Saguenay. Presentación de un caso espanol. Revista Neurol. 2000; 31: 36–3.Google Scholar
  8. 8.
    Dawson DM. Recessive ataxia with ocular motor apraxia. Arch Neurol 2001; 58: 173–174.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Richter A., Rioux J., Bouchard JP, et al. Location score and haplo- type analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. Am J Hum Genet 1999; 64: 768–775.PubMedCrossRefGoogle Scholar
  2. 2.
    Engert JC., Bérubé P., Mercier J, et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5kb ORF. Nat Genet 2000; 24: 120–125.PubMedCrossRefGoogle Scholar
  3. 3.
    Chaigne D., Brauer, E., Ruh D, et al. L’ataxie spastique autosomique recessive: étude clinique, neurophysiologique, opthalmologiques de IRM de deux cas familiaux. Rev Neurol. (Paris) 1993; 149: 585.Google Scholar
  4. 4.
    Mrissa N., Belal S., Hamida CB, et al. Linkage to chromosome 13q11–12 of an autosomal recessive cerebellar ataxia in a Tunisian family. Neurology 2000; 54: 1408–1414.PubMedGoogle Scholar
  5. 5.
    Pulst SM., Filla A. Ataxias on the march from Quebec to Tunisia. Neurology 2000; 54: 1400–1401.PubMedGoogle Scholar
  6. 6.
    Gücüyener K., özgül K., Paternotte C., Erdem H., Prud‘homme JF., Ozguc M., Topaloglu H. Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two unrelated Turkish families. Neuropediatrics 2001; 32: 142–146.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Friedreich N. Ueber Ataxie mit besonderer Berücksichtigung der hereditären Formen. Virchows Arch pathol Anat Physiol klin Med 1876; 68: 145–245.Google Scholar
  2. 2.
    Friedreich N. Ueber Ataxie mit besonderer Berücksichtigung der hereditären Formen (Nachtrag [Postscriptum]) Virchows Arch pathol Anat Physiol klin Med 1877; 70: 140–152.CrossRefGoogle Scholar
  3. 3.
    Menzel P. Beitrag zur Kenntnis der hereditären Ataxie und Kleinhirnatrophie. Arch Psychiat Nervenkrankh 1891; 22: 160–190.CrossRefGoogle Scholar
  4. 4.
    Dejerine J., Thomas A. L’atrophie olivo-ponto-cérébelleuse. Nouv Icon Salpêtrière 1900; 13: 330–37.Google Scholar
  5. 5.
    Greenfield JG. The spinocerebellar degenerations. Oxford: Blackwell; 1954: 35–66.Google Scholar
  6. 6.
    Marie P. Sur l’hérédo-ataxie cérébelleuse. Sem Méd 1893; 13: 444–447.Google Scholar
  7. 7.
    Rosenberg RN., Nyhan WL., Bay C, et al. Autosomal dominant striatonigral degeneration. Neurology 1976; 26: 703–714.PubMedGoogle Scholar
  8. 8.
    Becker PE., Sabuncu N., Hopf HC. Dominant erblicher Type von ‘cerebellarer Ataxie’. Z Neurol 1971; 199: 116–139.PubMedCrossRefGoogle Scholar
  9. 9.
    Koeppen AH. The hereditary ataxias. J Neuropathol Exp Neurol 1998; 57: 531–543.PubMedCrossRefGoogle Scholar
  10. 10.
    Tan EK., Ashizawa T. Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol 2001; 58: 191–195.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Zoghbi HY., Orr HT. Spinocerebellar ataxias. In: Scriver CR, Baudet AL, Sly WS, et al, editors. The metabolic and molecular bases of inherited disease. 8th edition. New York: McGraw-Hill, 2001: 5741–5758.Google Scholar
  2. 2.
    Orr HT., Chung MY., Banfi S, et al. Expansion of an unstable CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993; 4: 221–226.PubMedCrossRefGoogle Scholar
  3. 3.
    Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathol (Berl) 1995; 90: 572–581.CrossRefGoogle Scholar
  4. 4.
    Clark HB., Burright EN., Yunis WS, et al. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci 1997; 17: 7385–7395.PubMedGoogle Scholar
  5. 5.
    Klement IA., Skinner PJ., Kaytor MD, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA-1 transgenic mice. Cell 1998; 95: 41–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Clark HB., Orr HT. Spinocerebellar ataxia type 1—modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. J Neuropathol Exp Neurol 2000; 59: 265–270.PubMedGoogle Scholar

References

  1. 1.
    Huynh DP., Figueroa K., Hoang N., Pulst SM. Nuclear localization or inclusion body formation are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 2000; 26: 44–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Kiehl TR., Shibata H., Pulst SM. The ortholog of human ataxin-2 is essential for early embryonic patterning inC. elegans. J Mol Neurosci 2000; 15: 231–241.PubMedCrossRefGoogle Scholar
  3. 3.
    Shibata H., Huynh DP., Pulst SM. A novel protein with RNA binding motifs interacts with ataxin-2. Hum Mol Genet 2000; 9: 1303–1313.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Paulson HL., Bonini NM. Spinocerebellar ataxia type 3. Neurosci News 2000; 3: 87–93.Google Scholar
  2. 2.
    Paulson H., Bonini N., Roth K. Polyglutamine diseases and neuronal cell death. Proc Natl Acad Sci USA 2000; 97: 2957–2958.Google Scholar
  3. 3.
    Warrick J., Chan E., Gray-Board G, et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone Hsp70. Nat Genet 1999; 23: 425–428.PubMedCrossRefGoogle Scholar
  4. 4.
    Chan, HYE., Warrick JM., Gray-Board GL, et al. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy, and modulation of protein solubility in Drosophila. Hum Mol Genet 2000; 9: 2811–2820.PubMedCrossRefGoogle Scholar
  5. 5.
    Chai Y., Koppenhafer S., Bonini., N., Paulson H. Analysis of the role of heat shock protein (Hsp) chaperones in polyglutamine disease. J Neurosci 1999; 19: 10338–10347.PubMedGoogle Scholar
  6. 6.
    Chai Y., Wu L., Griffin J., Paulson H. The role of protein context in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem 2001; 276: 44889–44897.PubMedCrossRefGoogle Scholar
  7. 7.
    McCampbell A., Taye AA., Taylor JP, et al. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 2000; 9: 2197–2202.PubMedCrossRefGoogle Scholar
  8. 8.
    Perez M., Paulson H., Pittman R. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum Mol Genet 1999; 8: 2377–2385.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Tan EK., Ashizawa T. Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol 2001; 58: 191–195.PubMedCrossRefGoogle Scholar
  2. 2.
    Harding, AE. Clinical features and classification of inherited ataxias. Adv Neurol 1993; 61: 1–14.PubMedGoogle Scholar
  3. 3.
    Zhuchenko O., Bailey J., Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15: 62–69.PubMedCrossRefGoogle Scholar
  4. 4.
    Trottier Y., Lutz Y., Stevanin G, et al. Polyglutamine expansion as a pathological epitope in Huntington’s disease and four dominant cerebellar ataxias. Nature 1995; 378: 403–406.PubMedCrossRefGoogle Scholar
  5. 5.
    Gomez CM. Polyglutamine aggregates in SCA6 Purkinje cells: a tail of two toxicities. Neurology 2001; 56: 1619.Google Scholar
  6. 6.
    David G., Abbas N., Stevanin G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997; 17: 65–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Koob MD., Benzow KA., Bird TD, et al. Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. Nat Genet 1998; 18: 72–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Lebre AS., Jamot L., Takahashi J, et al. Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions. Hum Mol Genet. 2001; 10: 1201–1213.PubMedCrossRefGoogle Scholar
  9. 9.
    Zühlke C., Hellenbroich Y., Dalski A, et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 2001; 9: 160–164.PubMedCrossRefGoogle Scholar
  10. 10.
    Nakamura K., Jeong SY., Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001; 10: 1441–1448.PubMedCrossRefGoogle Scholar
  11. 11.
    Koob MD., Moseley ML., Schut LJ, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999; 21: 379–384.PubMedCrossRefGoogle Scholar
  12. 12.
    Moseley ML., Schut LJ., Bird TD, et al. SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. Hum Mol Genet 2000; 9: 2125–2130.PubMedCrossRefGoogle Scholar
  13. 13.
    Vincent JB., Neves-Pereira ML, et al. An unstable trinucleotiderepeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus. Am J Hum Genet 2000; 66: 819–829.PubMedCrossRefGoogle Scholar
  14. 14.
    Silveira I., Alonso I., Guimaraes L, et al. High germinal instability of the (CTG)n at the SCA8 locus of both expanded and normal alleles. Am J Hum Genet 2000; 66: 830–840.PubMedCrossRefGoogle Scholar
  15. 15.
    Holmes SE., O’Hearn EE., McInnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5’ region of PPP2R2B is associated with SCA12. Nat Genet 1999; 23: 391–392.PubMedCrossRefGoogle Scholar
  16. 16.
    Fujigasaki H., Verma IC., Camuzat A, et al. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol 2001; 49: 117–121.PubMedCrossRefGoogle Scholar
  17. 17.
    Matsuura T., Yamagata T., Burgess DL, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000; 26: 191–194.PubMedCrossRefGoogle Scholar

References

  1. 1.
    Vig PJS., Fratkin JD., Desaiah D, et al. Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia 1. Neurology 1996; 47: 249–253.PubMedGoogle Scholar
  2. 2.
    Vig PJS., Subramony SH., Burright EN, et al. Reduced immunoreactivity to calcium binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia 1. Neurology 1998; 50: 106–113.PubMedGoogle Scholar
  3. 3.
    Vig PJS., Subramony SH., Qin Z, et al. Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice. J Neurol Sci 2000; 174: 100–110.PubMedCrossRefGoogle Scholar
  4. 4.
    Lin X., Antalffy B., Kang D, et al: Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA 1. Nat Neurosci 2000; 3: 157–163.PubMedCrossRefGoogle Scholar
  5. 5.
    Vig PJS., Subramony SH., McDaniel DO: Calcium homeostasis and spinocerebellar ataxia 1. Brain Res Bull 2001; 56: 221–225.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2002

Authors and Affiliations

  1. 1.Department of NeurologyBaylor College of MedicineHoustonUSA
  2. 2.University of Minnesota Medical SchoolMinneapolisUSA
  3. 3.Albany Medical College, Chief, Neurology Service (127)VA Medical CenterAlbanyUSA
  4. 4.Université Libre de Bruxelles, Chef de serviceService de neurologie Hôpital ErasmeBruxellesBelgium
  5. 5.Programs in Genetics and NeuroscienceUniversity of Iowa College of MedicineIowa CityUSA
  6. 6.Cedars-Sinai Medi cal CenterUCLA School of MedicineLos AngelesUSA
  7. 7.Service de Génétique MédicaleHôpital Ste-JustineQuebecCanada
  8. 8.University of Montreal, Adjunct Professor of Neurosurgery, Neurology, and PathologyMcGill University, Département de pathologie, Hôpital Ste-JustineMontréal, QuébecCanada
  9. 9.Department of NeurologyUniversity of Mississippi Medical CenterJacksonUSA
  10. 10.Department of Pathology and Laboratory MedicineUniversity of Pennsylvania, Room 509A, Stellar-Chance LaboratoriesPhiladelphiaUSA

Personalised recommendations